Impact of antenatal care on severe maternal and neonatal outcomes in pregnancies complicated by preeclampsia and eclampsia in Ghana
Beyuo, Titus K; Lawrence, Emma R; Oppong, Samuel A; Kobernik, Emily K; Amoakoh-Coleman, Mary; Grobbee, Diederick E; Browne, Joyce L; Bloemenkamp, K W M
(2023) Pregnancy Hypertension, volume 33, pp. 46 - 51
(Article)
Abstract
Objectives: To explore how specific measures of antenatal care utilization are associated with outcomes in pregnancies complicated by preeclampsia and eclampsia in Ghana. Study Design: Participants were adult pregnant women with preeclampsia or eclampsia at a tertiary hospital in Ghana. Antenatal care utilization measures included timing of first visit, total
... read more
visits, facility and provider type, and referral status. Antenatal visits were characterized by former and current World Health Organization recommendations, and by gestational age-based adequacy. Main Outcome Measures: Composites of maternal complications and poor neonatal outcomes. Multivariate logistic regressions identified associations with antenatal care factors. Results: Among 1176 participants, median number of antenatal visits was 5.0 (IQR 3.0–7.0), with 72.9% attending ≥4 visits, 19.4% attending ≥8 visits, and 54.9% attending adequate visits adjusted for gestational age. Care was most frequently provided in a government polyclinic (n = 522, 47.2%) and by a midwife (n = 704, 65.1%). Odds of the composite maternal complications were lower in women receiving antenatal care at a tertiary hospital (aOR 0.47, p = 0.01). Odds of poor neonatal outcomes were lower in women receiving antenatal care at a tertiary hospital (aOR 0.56, p < 0.001), by a specialist Obstetrician/Gynecologist (aOR 0.58, p < 0.001), and who attended ≥8 visits (aOR 0.67, p = 0.04). Referred women had twice the odds of a maternal complication (aOR 2.12, p = 0.007) and poor neonatal outcome (aOR 1.68, p = 0.002). Conclusions: Fewer complications are seen after receiving antenatal care at tertiary facilities. Attending ≥8 visits reduced poor neonatal outcomes, but didn't impact maternal complications. Quality, not just quantity, of antenatal care is essential.
show less
Download/Full Text
The full text of this publication is not available.
Keywords: Antenatal care, Eclampsia, Hypertensive disorders of pregnancy, LMIC, Preeclampsia, Prenatal care, Obstetrics and Gynaecology, Internal Medicine, Journal Article
ISSN: 2210-7789
Publisher: Elsevier BV
Note: Funding Information: Titus Beyuo: I declare that I participated in the conceptualization, study protocol development, data collection and management, data interpretation, and manuscript editing and review for this study and that I have seen and approved the final version of the manuscript. I have no conflicts of interest. Titus Beyuo was supported by a VECD Global Health Fellowship funded by the Fogarty International Center (FIC) of the National Institutes of Health (D43 TW009337). Funding Information: We thank Hassan Kaleem and Andrew Owusu for leadership in data collection and entry. Data statement, The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request. This work was supported by the Rudi Ansbacher Research Award, University of Michigan Department of Obstetrics and Gynecology and Women's Health Leadership Board Innovation Fund, University of Michigan. Contributors:, Titus Beyuo: I declare that I participated in the conceptualization, study protocol development, data collection and management, data interpretation, and manuscript editing and review for this study and that I have seen and approved the final version of the manuscript. I have no conflicts of interest. Titus Beyuo was supported by a VECD Global Health Fellowship funded by the Fogarty International Center (FIC) of the National Institutes of Health (D43 TW009337). Emma R. Lawrence: I declare that I participated in the study protocol development, data collection and management, data interpretation, and manuscript editing and review for this study and that I have seen and approved the final version of the manuscript. I have no conflicts of interest. Samuel Oppong: I declare that I participated in the conceptualization, study protocol development, data collection and management, data interpretation, and manuscript editing and review for this study and that I have seen and approved the final version of the manuscript. I have no conflicts of interest. Emily K. Kobernik: I declare that I participated in the data analysis, data interpretation, and manuscript editing and review for this study and that I have seen and approved the final version of the manuscript. I have no conflicts of interest. Mary Amoakoh-Coleman: I declare that I participated in the data interpretation, and manuscript editing and review for this study and that I have seen and approved the final version of the manuscript. I have no conflicts of interest. Diederick E. Grobbee: I declare that I participated in the data interpretation, and manuscript editing and review for this study and that I have seen and approved the final version of the manuscript. I have no conflicts of interest. Joyce L. Browne: I declare that I participated in the data interpretation, and manuscript editing and review for this study and that I have seen and approved the final version of the manuscript. I have no conflicts of interest. K.W.M. Bloemenkamp: I declare that I participated in the data interpretation, and manuscript editing and review for this study and that I have seen and approved the final version of the manuscript. I have no conflicts of interest. Funding Information: This work was supported by the Rudi Ansbacher Research Award, University of Michigan Department of Obstetrics and Gynecology and Women’s Health Leadership Board Innovation Fund, University of Michigan. Publisher Copyright: © 2023 International Society for the Study of Hypertension in Pregnancy
(Peer reviewed)